DISA (SG:532) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
DISA Limited’s subsidiary, Digital Life Line Pte. Ltd., has signed an MOU with Vietnam’s Medical Saigon Group to trial its Automated Visual Acuity Test Device and AI-based retinal imaging in 13 hospitals. This partnership, backed by global investment firm KKR & Co., aims to enhance eye care services through innovative technology that streamlines testing and treatment processes. The AVAT device, developed by Singapore’s National University Hospital, offers an efficient, self-administered visual acuity test that addresses staffing and space challenges.
For further insights into SG:532 stock, check out TipRanks’ Stock Analysis page.